Noel R, Hammad T, Jhuaeri J, Hauber B. Weighing the benefits & risks: the science and methods of benefit-risk assessment in drug development. Presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 19, 2020. Previously presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.


Benefit-risk assessment is now a fundamental science for understanding and evaluating the development, approval, and continued marketing of drugs and devices. This course is aimed at introducing attendees to core concepts and tools of both the science and practice of benefit-risk assessment.

Share on: